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The possibility of changing the number of synapses may be an important asset in the treatment of neurological diseases. In this context,
the synaptogenic role of the phosphoinositide-3-kinase (PI3K) signaling cascade has been previously demonstrated in Drosophila. This
study shows that treatment with a PI3K-activating transduction peptide is able to promote synaptogenesis and spinogenesis in primary
cultures of rat hippocampal neurons, as well as in CA1 hippocampal neurons in vivo. In culture, the peptide increases synapse density
independently of cell density, culture age, dendritic complexity, or synapse type. The induced synapses also increase neurotransmitter
release from cultured neurons. The synaptogenic signaling pathway includes PI3K-Akt. Furthermore, the treatment is effective on adult
neurons, where it induces spinogenesis and enhances the cognitive behavior of treated animals in a fear-conditioning assay. These
findings demonstrate that functional synaptogenesis can be induced in mature mammalian brains through PI3K activation.
Introduction
In mammals, class IA phosphoinositide-3-kinase (PI3K) is a het-
erodimer formed by a 110 kDa catalytic subunit (p110, p110,
or p110) and a smaller regulatory subunit (p85, -, and -,
p55, and p50) (Wymann and Pirola, 1998). The p85 subunit
binds, stabilizes, and inhibits p110 activity (Yu et al., 1998). Fol-
lowing the activation of a tyrosine kinase receptor, the p85–p110
complex is recruited to the receptor alleviating p110 inhibition,
leading to the production of phosphatidylinositol 3,4,5-tris-
phosphate (PIP3) from phosphatidylinositol 4,5-bisphosphate
(PIP2) (Vanhaesebroeck et al., 2001). PIP3 acts as secondmessen-
ger by recruiting to the membrane and activating the Akt kinase,
which in turn results in the phosphorylation of downstream tar-
gets, including glycogen synthase kinase 3 (GSK3) and mamma-
lian target of rapamycin (mTOR) (Ruggero and Sonenberg,
2005).
In neurons, the PI3K pathway controls a variety of neuronal
responses. In addition to its role in neuronal survival (Brunet et
al., 2001), PI3K has been implicated in dendritic morphogenesis
(Jaworski and Sheng, 2006), neuronal polarity and growth (Jiang
and Rao, 2005), synaptic plasticity (Opazo et al., 2003), memory
formation (Lin et al., 2001), and AMPA receptors clustering at
the postsynaptic density (Arendt et al., 2010). Conversely, alter-
ations in the Akt pathway are important features in several
neurodegenerative diseases, including Huntington’s disease
(Humbert et al., 2002) and Alzheimer’s disease (Griffin et al.,
2005).
In Drosophila, overexpression of the catalytic subunit Dp110
(homolog to human p110) increases the number of functional
synapses in larval and adult fly neurons, independently of cell size
or proliferation (Martín-Pen˜a et al., 2006). The actual PI3K-
dependent synaptogenic pathway also involves Akt–GSK3 signal-
ing; thus, overexpression of Akt results in a synaptic increase
similar to that produced by Dp110, and overexpression of GSK3
reduces the number of synapses, while GSK3 downregulation
increases axonal growth and synaptic terminals (Franco et al.,
2004; Martín-Pen˜a et al., 2006).
In mammalian neurons, there is some evidence suggesting
that the PI3K/Akt/GSK3 pathway plays a role in synaptogenesis
and spinogenesis. Thus, the selective elimination of phosphatase
and tensin homolog (PTEN), a lipid phosphatase that dephos-
phorylates PIP3 and reverses PI3K activation, causes Akt overac-
tivation, resulting in dendritic hypertrophy, increased spine
density, and, finally, macrocephaly (Kwon et al., 2006). More-
over, GSK3 activity has been implicated in axon formation, given
that constitutively activemutants inhibit this formation, whereas
loss-of-function mutants promote the formation of multiple ax-
ons (Jiang et al., 2005; Yoshimura et al., 2006). Furthermore,
mTOR and S6 kinase (S6K), downstream components of the
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PI3K/Akt pathway, are present in the synapse and have been
shown to mediate synaptic plasticity and dendritic elongation
(Tang et al., 2002; Tsokas et al., 2005).
In the present study, using a peptide mimetic of the pTyr
domain of the PDGF receptor to increase PI3K activation
(Derossi et al., 1998), we show that PI3K activation induces syn-
aptogenic and spinogenic effects on primary cultures of rat hip-
pocampal neurons and also on CA1 hippocampal neurons in
vivo. Furthermore, these morphological changes are functional
according to the criteria of increased basal neurotransmitter re-
lease, and correlate with an enhancement of cognitive behavior in
the treated animals. These data provide proof of the notion that




Primary cultures of hippocampal neurons were prepared from postnatal
[postnatal day (P) 0–P1] rat pups, as previously described (Banker and
Goslin, 1998; Morales et al., 2000). Glass coverslips (12 mm in diameter)
were coated with poly-L-lysine (100 g/ml) and laminin (4 g/ml). In
brief, hippocampal neurons were seeded at 15  104/cm2 in a culture
medium consisting of Neurobasal medium (Invitrogen) supplemented
with glutamine 0.5 mM, 50 mg/ml penicillin, 50 U/ml streptomycin, 4%
FBS, and 4% B27 supplement (Invitrogen). After 4, 7, 14, and 21 d in
culture, 100 l (of a total of 500 l) of culture medium was replaced by
120 l of fresh medium. On day 4, 4 M cytosine-D-arabinofuranoside
was added to prevent overgrowth of glial cells.
Transfection
Electroporation before plating was performed using the kit from
AMAXA. To this end,2 106 cells were mixed with 10 g of plasmid
and then electroporated, following themanufacturer’s instructions. Two
expression vectors were used: an empty vector cytomegalovirus (CMV)-
enhanced green fluorescent protein (eGFP)-N1 (Clontech) and a vector
plasmid encoding theGFP protein chimeric with theN terminus of chick
-actin under the control of the platelet-derived growth factor enhancer/
promoter region (kindly provided by Y. Goda, MRC Cell Biology Unit,
University College London, London, UK) (Colicos et al., 2001).
PI3K-activating peptides
Control activation of PI3K activity was achieved by using a peptide
named PTD4-PI3KAc, which consists of a transduction domain, PTD4
[Tyr-Ala-Arg-Ala-Ala-Ala-Arg-Gln-Ala-Arg-Ala (Ho et al., 2001)],
fused to a phosphopeptide containing the intracellular phosphorylated
domain of the PDGF receptor C terminus [Gly-Ser-Asp-Gly-Gly-pTyr-
Met-Asp-Met-Ser (Derossi et al., 1998)]. A series of peptides containing
only the PTD4 transduction domain by itself or fused to rhodamine or
FITCwere used as controls. All peptides were purchased fromGenScript.
Immunocytochemistry and image analysis
Immunocytochemical analysis was performed on hippocampal neuronal
cultures from 1 to 3 weeks in vitro. Cultures were rinsed in PBS and fixed
for 30 min in 4% paraformaldehyde in PBS. Coverslips were washed
three times in PBS and incubated for 30 min in blocking solution (2%
goat serum, 2% serum albumin, 0.2% Triton X-100 in PBS). Antibodies
were diluted to the appropriate concentration in blocking solution. Cov-
erslips were incubated for 60 min in the antibody solution. The samples
were subsequentlywashed three times in PBS and incubated for 30min in
PBS solution containing the fluorescence-conjugated secondary anti-
bodies, and then washed five times with PBS and mounted in Mowiol.
Fluorescence images were obtained with an invertedmicroscope (Olym-
pus IX70), using a TILL monochromator as light source. Pictures were
taken with an attached cooled CCD camera (Orca II-ER, Hamamatsu).
ImageJ analysis software (National Institutes of Health) was used for
synaptic density and dendritic length quantification. To reduce variabil-
ity among different cultures and treatments, synaptic puncta were exclu-
sively analyzed in proximal dendrites, starting from a clearly identified
neuronal cell soma. Synaptic density represents the number of synapses
per 100 micrometers of dendritic length. Hippocampal cultures were
routinely treated with the peptide for 48 h, unless otherwise indicated.
Synaptic density shows some degree of variability among cultures (from
10 to 29 synapses per 100m at day 10 in vitro). To normalize data from
different cultures, the percentage of synaptic changewas calculated as the
average of different cultures under the same experimental conditions. As
a control, we used sister untreated cultures grown in the same multiwell
plate.
The following antibodies were used: an anti-bassoon monoclonal an-
tibody (catalog #VAM-PS003, Stressgen), a polyclonal sera against syn-
apsin (catalog #2312, Cell Signaling Technology), and a monoclonal
antibody against gephyrin (catalog #147011, Synaptic Systems), as well as
the appropriate secondary antibodies (Invitrogen). To analyze spine
density, cultures of GFP–actin-transfected neurons were fixed and pro-
cessed in a similar manner. Spine pictures were taken with a Leica DMI
6000B microscope coupled to a Leica DFC 350 FX camera. ImageJ soft-
ware was used to quantify spine densities.
Sholl analysis
Neuronal branching complexity was analyzed as follows: at days 4 and 6
in culture, low-density hippocampal cultures were stained with an anti-
body against MAP2B (Cell Signaling Technology). At days 10 and 21, we
used the GFP-transfected neurons on high-density cultures. Using Im-
ageJ software, low-magnification pictures from isolated neurons were
digitally enhanced. Afterward, a series of concentric circles were drawn,
centered on the cell body and gradually increasing in diameter in 20 m
steps. A two-dimensional analysis was performed, counting the number
of branches that intersected successive concentric circles (Sholl, 1953).
Contour pictures were obtained from the same pictures following digital
thresholding, using ImageJ software.
Electrophysiology
Spontaneous miniature EPSCs (mEPSCs) were recorded starting on day
12 in culture. The recording chamber was filled with a solution contain-
ing 137 mM NaCl, 5 mM KCl, 3 mM CaCl2, 0.5 mM MgCl2, 10 mM
D-glucose, and 10mMHEPES-NaOH, pH 7.3, adjusted to 310mOsm/kg.
Tetrodotoxin (TTX) was used at a concentration of 1 M. Whole-cell
patch-clamp recordings were performed with electrodes filled with the
following solution: 135 mM K-gluconate, 18 mM KCl, 9 mM NaCl, 1 mM
MgCl2, 10 mM HEPES-KOH, pH 7.2, and 0.3 mM EGTA adjusted to 300
mOsm. An ATP regeneration mix (2 mM ATP, 10 mM phosphocreatine,
0.5 mM GTP, 2 mMMgCl2, 0.5 mM GTP, and 25 U/ml creatine phospho-
kinase) was routinely added to the internal solution. mEPSCs were re-
corded at a sampling frequency of 10 kHz. Frequency analysis was
performed using Clampfit Event Detector software (Molecular Devices).
Western blot quantification
Cell culture. Hippocampal neurons were seeded at 50  104/cm2 on
coated wells from a 24-well plate. Before lysis, the wells were washed two
times with PBS (4°C) and then scrapped in 60l of lysis buffer (62.5 mM
Tris HCl, pH 6.8, 2% SDS, 10% glycerol, 100 mM DTT and 0.01% bro-
mophenol blue). Cell lysates were collected and boiled at 85°C for 3 min,
sonicated during 5 min, and finally clarified by centrifugation at
17,000 g. The supernatants were stored frozen at80°C. Samples were
subjected to SDS-PAGE andWestern blotting. Signals were detectedwith
a chemoluminescent detection system (Immun-Star HRP, Bio-Rad).
Signal detection and density quantification were performed using a LAS
3000 Image system (Fuji). The following antibodies were used: anti-actin
monoclonal antibody (catalog #A2547, Sigma), and polyclonal antibod-
ies against Phospho-Akt (Ser473) and Akt (catalog #9271 and #4691,
respectively, Cell Signaling Technology). LY294002, Akt 1/2 kinase in-
hibitor, and deguelin were purchased from Sigma. Unless otherwise in-
dicated, in all biochemical experiments the peptide was added on day 10
in vitro, and cell lysis was performed 48 h later, on day 12. Control
cultures were performed simultaneously. Phospho-Akt values were re-
lated to the total Akt amount, while synapsin and PSD95 were related to
Actin levels. Average changes in phosphorylation and protein percentage
values were normalizedwith respect to the control value, always included
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in the sameWestern blotmembrane. Values100 indicate an increase in
protein levels; values100 indicate a reduction.
Brain tissue. Briefly, hippocampi were isolated from rat brain and
homogenized in lysis buffer containing commercial cell lysis buffer (cat-
alog #9803, Cell Signaling Technology) with the following supplements:
leupeptin 1g/ml, aprotinin 1g/ml, orthovanadate 1g/ml, andPMSF
1 M. The homogenate was centrifuged at 8000 rpm for 10 min, and the
supernatant was collected. Protein concentration was determined using
the Protein-Assay reagent (Bio-Rad). ForWestern blots, 40g of sample
were loaded. Signals were detected using the corresponding infrared-
fluorescence-labeled antibodies (Li-Cor Bioscience) and viewed with an
Odyssey Infrared Imaging System (Li-Cor Bioscience).
Stereotaxis and immunohistochemistry
Male adult Sprague Dawley rats (275–300 g) were purchased from Har-
lan. Before the experimental procedure, the animals were kept in the
animal housing unit for 1 week. Animals were anesthetized with a mix-
ture of xylazine (10 mg/kg) and ketamine (70 mg/kg) and were placed in
a stereotaxic frame. Injections using a Hamilton syringe were adminis-
tered into the CA1 region of the dorsal hippocampus (bregma coordi-
nates: 2.8 mm anteroposterior, 1.5 mm lateral, and 2.8 mm
dorsoventral) (Paxinos and Watson, 1998). All rats received a total vol-
ume of 1 l per injection. A construct of PTD4-rhodamine (100 M)
diluted in CSF was injected in the case of control animals, while PTD4-
PI3KAc (10 g/l) diluted in water and 6% DMSO was injected in the
experimental group. Seventy-two hours after the stereotaxic injections,
the animals were perfused transcardially with saline and 4% phosphate-
buffered paraformaldehyde. Brain sections (100 m) including the dor-
sal hippocampus were obtained using a vibratome (VT-1000S, Leica)
and stained with DAPI (Sigma). With the aid of a micromanipulator,
individual neurons were injected by microiontophoresis with Lucifer
yellow (8% in 0.1 M Tris buffer, pH 7.4) (Elston and Rosa, 1997;
Benavides-Piccione et al., 2002; Ballesteros-Ya´n˜ez et al., 2006). The mi-
crocapillary containing the neuronal tracer was backfilled with LiCl (0.1
M). Neurons were filled under fluorescence microscopy by applying a
continuous current (20 nA) for 5 min. The tissue was processed for
immunohistochemistry with an antibody against Lucifer yellow (Sigma)
and identified by a goat anti-rabbit secondary antibody conjugated to
Alexa488 (Invitrogen). Only basal dendrites were selected for the analysis
of spine density. Images stacked to different z-levels were taken under
confocal microscopy, and a maximum intensity z-projection image was
composed using ImageJ software.We have only quantified lateral spines,
ignoring spines located on the top or bottom surface of the dendrites;
thus, only spines arising from the lateral surfaces of the dendrites were
included in the study. We can therefore assume that the results obtained
were presumably an underestimate of the total number of spines. Be-
cause spine density has been shown to increase as a function of the
distance from the soma, reaching a plateau 45 m away from it (Ruiz-
Marcos and Valverde, 1969; Elston and DeFelipe, 2002), to compare
different cells we selected dendritic segments of the same length starting
45 m away from the cell body.
Behavioral experiments
A total of 44male adult SpragueDawley rats (Harlan), weighing 250–275
g at the beginning of the experiment, were individually housed in cages
upon arrival and allowed to habituate to the animal housing conditions
for at least 1 week before starting the experimental procedures. Light (12
h light/dark cycle) and temperature (20°C) conditions were controlled,
and food andwater were providedwithout restriction. Rats were handled
daily for 2 min/d during the 3 d preceding the behavioral tests. After the
habituation period, the rats were implanted with stainless steel guide
cannulas aimed at the right lateral ventricle. They were anesthetized with
xylazine (10 mg/kg) and ketamine (70–100 mg/kg), and mounted in a
stereotaxic apparatus. A small hole was drilled through the skull, above
the right lateral ventricle (1 mm posterior, 1.5 mm lateral, and 4.3 mm
deep, relative to Bregma) (Paxinos and Watson, 1998), for implanting a
stainless steel 22G cannula with a Teflon guide and fitted with a remov-
able dummy cannula (Plastic One). The cannula was fixed to the skull
with dental acrylic (Duralay 2244, Reliance). After the surgery, the ani-
mals were allowed to recover for at least 5 d before performing the be-
havioral tests. Animal care procedures were conducted in accordance
with the guidelines set by European Community Council Directive 86/
609/EEC and the Cantonal Veterinary Authorities (Vaud, Switzerland).
Elevated plus maze
Animals were subjected to an Elevated Plus Maze protocol (EPM) to
assign them to groups of equivalent anxiety levels. The EPM consisted of
two opposing open arms (45 10 cm) and two closed arms (45 10
50 cm) extending from a central platform (10 10 cm) elevated 65 cm
above the floor. The ratswere individually placed on the central platform,
facing a closed arm, and were allowed to explore the maze freely for 5
min. The behavior of each rat was monitored using a video camera, and
the movements of the rats were automatically recorded and analyzed
using a computerized tracking system (Ethovision 3.0, Noldus Informa-
tion Technology). Entry into an arm was defined as the entry of all four
paws into the arm.
Fear conditioning
Two experiments were performed to evaluate whether in vivo intracere-
bral ventricular injection with the PTD4-PI3KAc would affect the estab-
lishment of fear-conditioning memories. The first experiment was
designed to evaluate the hippocampus-dependent, contextual, fear-
relatedmemory [contextual fear conditioning (CFC)], and the second to
assess the hippocampus-independent, auditory, fear-related memory
[auditory fear conditioning (AFC)]. In both experiments, the animals
were injected with 10 l of a CSF solution containing either 10 g of
PTD4-PI3KAc or 10 g of PTD4 control peptide. Twenty-four hours
after injection, the animals were submitted to a training session. Both
training and testing took place in two identical rodent observation cages
(30  37  25 cm), placed inside a sound-attenuating chamber. The
floor of each cage consisted of 20 steel rods wired to a shock source and
solid-state scrambler for the delivery of footshock stimuli (Panlab). Just
before the experiment, the animals to be subjected to training or test-
ing were transported from the colony room to the adjacent fear-
conditioning room. The conditioning chamber was thoroughly cleaned
between animals with 1% acetic acid. During the training, the animal was
allowed to freely explore the chamber for 160 s. This was followed by
three presentations of tone-shock pairings in which the tone (20 s; 800
Hz, 80 dB) coterminated with a foot shock (0.5 mA, 1 s). The intertone
interval was 40 s. Thirty seconds after the last shock, the animals were
removed and placed in their home cages in the colony room. Testing was
performed 1d later. In theCFC experiment, the animalswere exposed for
6 min to the training context, and on the following day to a context
discrimination test (i.e., a novel chamber with a different contextual
background). In the AFC experiment, 160 s after introducing the animals
into a new context, they were presented with the same tone used for
conditioning (800 Hz, 80 dB) for a period of 5 min. In all cases, the
animal’s behavior was video recorded and later scored with the help of a
video tracking system (Ethovision 3.0, Noldus Information Technology)
by a researcher blind to the treatment. Freezing was scored as an index of
fear, and defined as behavioral immobility (except for respiration move-
ments) for at least 2 s. For statistical analyses, freezing times were trans-
formed into freezing percentage values.
Statistics
All data are represented as means SEM and were analyzed using Prism
software (version 4.0, Graphpad). The data were analyzed using the Stu-
dent’s t test when appropriate. Significant levels were noted as follows:
*p 0.05, **p 0.01, and ***p 0.001.
Results
The cell membrane transduction peptide stimulates
PI3K activity
The effects of PI3K activation on synaptogenesis were analyzed
using the peptide PTD4-PI3KAc. This peptidemimics phosphor-
ylated tyrosine kinase receptor residues by binding to the p85
regulatory subunit of PI3Kwith great specificity. First, we verified
the peptide ability to activate PI3K by measuring the phosphor-
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ylation levels of Akt, a downstream effec-
tor of PI3K. Serum-starved SH-SY5Y
human neuroblastoma cells were treated
with a peptide concentration of 50g/ml,
and the levels of phospho-Akt (Ser473)
were quantified at 30, 60, 90, 180, and 360
min by Western blot (supplemental Fig.
S1, available at www.jneurosci.org as sup-
plemental material). PTD4-PI3KAc in-
duced amodest, but sustained, increase in
phospho-Akt levels from 152.7% after 30
min to 219.9% after 360min (supplemen-
tal Fig. S1, available at www.jneurosci.org
as supplemental material). As a negative
control, cells were treated with the PTD4
peptide (50g/ml) without the p85 inter-
action domain; its application did not
modify phospho-Akt levels (supplemen-
tal Fig. S1, available at www.jneurosci.org
as supplemental material). These data in-
dicate that the peptide was able to stimu-
late PI3K activity, an effect that remained
constant throughout the entire experi-
mental period.
PI3K stimulation increases the density
of synapses
Rat hippocampal neurons in culture were
used as a model. Two different presynap-
tic protein markers were used to identify
mature synapses: bassoon, a component
of the presynaptic cytoskeleton at the
active zone, and synapsin, a ubiquitous
vesicular presynaptic protein (Ziv and
Garner, 2004) (Fig. 1A). The overlapping
of these two signals was the criterion used
to identify synapses and to analyze the
changes in synaptic density in response to
PI3K activation (Friedman et al., 2000;
Shapira et al., 2003).
First, we characterized the synaptic ef-
fect of PTD4-PI3KAc by quantifying the
increase in the number of synapses in 10
day cultured neurons in response to three
concentrations of the peptide (0.5, 5, and
50 g/ml) during a 48 h treatment. Since
PTD4-PI3KAc mimics the intracellular C
terminus of the PDGF receptor, we used
PDGF (10 ng/ml) as a positive control. To
discard any possible effects due to the
transduction process itself, the cultures
were treated with 5 g/ml a peptide con-
taining only the transduction domain
(PTD4). The quantification of the density
of synapses indicates that the effects
started at 0.5g/ml (24% increment) and
reached its maximum at a concentration
between 5 and 50 g/ml (67% and 49%
increments, respectively) (Fig. 1B). In
contrast, PDGF application alone did not show any synaptogenic
effect (Fig. 1B) nor did the transduction fragment PTD4 (Fig. 1C).
Second, due to the peptidic nature of this activator, we
investigated the temporal window of the synaptic increase,
adding a single dose at day 2 in culture (5 g/ml) and quanti-
fying the effects after 96 and 144 h. The data show that the
synaptogenic effects remain for 96 h (Fig. 1D). At 144 h (day 8
in vitro), the synaptic density was similar to that of the un-
Figure 1. Concentration and time dependence of PI3K synaptogenic effects.A, Hippocampal neurons in culture double stained
with anti-bassoon and anti-synapsin antibodies. Mature synapses were quantified only if positive puncta to both bassoon and
synapsin overlapped, and only from dendrites starting from a clearly identified neuronal cell body (scale bar, 5m). B, Single
dose-response curve after applying PTD4-PI3KAc at different concentrations on day 10 in vitro and quantifying synaptic density on
day 12. Control experiments were performed in the presence of PDGF (10 ng/ml). The maximum effect of PTD4-PI3KAc was
obtained using a concentration of 5g/ml. A higher concentration of 50g/ml resulted in no further increase (Student’s t test).
White bars: untreated cultures. Black bars: Treated cultures. (n 80 neurons, two cultures). C, Transduction control. Synaptic
density changes after applying 5g/ml transduction peptide alone (PTD4) under the same conditions. No changes in synaptic
density were observed after 48 h of treatment.White bars: untreated cultures. Gray bars: PTD4 (n 30 neurons, two cultures).D,
Peptide half-life in vitro. Time course of the effect of PTD4-PI3KAc after a single application of 5g/ml of the peptide on day 2 in
vitro. The peptide remained active for at least 4 d in culture. Synaptic density was analyzed after 96 and 144 h. A Student’s t test
indicated significant differences after 96 h, with no differences after 144 h. White bars: untreated cultures. Black bars: treated
cultures. (n 60 neurons, three cultures). E, Minimum time required for peptide effects. PTD4-PI3KAc effects on the density of
synapses were manifest after a minimum of 24 h. Nine-day-old cultures were treated with 5g/ml PTD4-PI3KAc, the cells were
fixed, and the density of synapses was quantified at the indicated intervals. The graph represents the percentage of increase with
respect to the untreated cultures. A statistically significant difference was only detected 24 h after the addition of PTD4-PI3KAc
(Student’s t test; n 50, two cultures). F, Representative immunoblot showing the changes in PSD95, synapsin and phospho-Akt
(Ser-473) fromahigh-density hippocampal neuron culture treatedwith PTD4-PI3KAc (50g/ml), PTD4 (50g/ml), or LY294002
(5M). Treatment was applied on day 10, and cellular lysis was conducted on day 12 in vitro. G, Summary graph of PI3K activity.
PTD4-PI3KAc-treated cultures exhibited increased levels of phospho-Akt, synapsin and PSD95, compared with untreated cultures
(n 33, eight cultures). The transduction peptide PTD4 alone failed to modify either Akt phosphorylation or protein expression
levels (n 4, three cultures). Conversely, LY294002 significantly reduced phospho-Akt and synapsin levels (n 7, two cultures).
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treated cultures, indicating that the peptide was no longer
active (Fig. 1D).
Third, we determined the minimum period of time required
to increase the density of synapses. Nine-day-old neuronal cul-
tures were treated with a single dose of PTD4-PI3KAc (5g/ml),
and the density of synapses was quantified after 1, 3, 6, 12, and
24 h (Fig. 1E). The synaptogenic effect, normalized to untreated
cultures, indicates a significant difference only after 24 h (57.1
18.7% increment). This value represents the time it takes for a
synapse to be built after PI3K overactivation, and it is in agree-
ment with the value obtained in Drosophila following PI3K gene
activation (Martín-Pen˜a et al., 2006).
Finally, we measured the ability of the peptide to modulate
Akt phosphorylation in hippocampal cultures. The basal phos-
phorylation levels of Akt in neuronal cultures, and consequently
its activity levels, were highly variable. To obtain a more robust
and constant effect, the peptide concentration was raised to 50
g/ml (Fig. 1F). After 48 h of treatment, Akt phosphorylation at
residue Ser-473 increased to 142 18.2% over the control levels.
Noticeably, this increase is compatible with the effect on synaptic
density; furthermore, it demonstrates that the peptide remained
active during this window of time. As expected, the addition of
the PI3K inhibitor LY294002 (5 M) reduced Akt phosphoryla-
tion levels down to 64.1 3.8% (Fig. 1G). The control treatment
using 50 g/ml PTD4 did not significantly modify the basal Akt
phosphorylation levels (97.4 2.5%).
To further confirm the synaptogenic effects and to establish a
reliable protein marker of synaptogenesis, we quantified the
changes in the expression levels of synapsin, a ubiquitous com-
ponent of all presynaptic terminals (Sudhof, 2004). In parallel to
the phospho-Akt augmentation, PTD4-PI3KAc increased synap-
sin levels up to 129.8 18.5%. On the other hand, in addition to
decreasing phospho-Akt levels, treatment with LY294002 re-
duced synapsin levels to 64.9  10.5%, compared with the un-
treated control cells. Cultures treated with PTD4 failed to show
any change in synapsin expression (83.1 9.6%) (Fig. 1F,G).
Additionally, we quantified the levels of PSD95, a major post-
synaptic component specific to glutamatergic synapses. While
PTD4-PI3KAc increased PSD95 up to 127.1  7.6%, neither
PTD4 nor the PI3K inhibitor affected its levels (Fig. 1F,G). Thus,
it can be concluded that the expression levels of two synaptic pro-
teins and the phosphorylation of a PI3K target substratum are con-
sistently modified by the upregulation or downregulation of PI3K
activity.
In summary, the experiments described in this section helped
us establish a working concentration and a time window for the
synaptogenic effects of PTD4-PI3KAc, from a minimum time of
24 h to a maximum of 96 h.
The synaptogenic effects of PI3K activation are independent
of culture age and synapse type
In culture, hippocampal neurons develop extensive axonal and
dendritic arbors, and form numerous synapses in a short period
of time. Presynaptic specializations do not appear until day 3,
even though numerous cell contacts can be observed during the
first 24 h (Fletcher et al., 1994; Friedman et al., 2000). Whereas
axons can develop presynaptic specializations soon after they
emerge from the cell soma, dendrites do not have the capability to
induce synapses until they reach a critical maturation stage, usu-
ally after 5 d in culture (Fletcher et al., 1994; Ziv and Garner,
2001). Later, during the second and third weeks, hippocampal
neurons grow into a dense network of dendrites, with spines
appearing after 16–18 d in culture (Kaech and Banker, 2006). To
cover all the developmental stages, we examined whether PI3K
induces synaptic changes under two conditions: during a 2 week
chronic treatment period, and after an acute single treatment of
48 h in 2- and 3-week-old cultures.
During the chronic experiment, the peptide PTD4-PI3KAc
was added (5 g/ml) every other day, starting on day 2 and con-
tinuing until day 12. Cultures were fixed and processed for im-
munostaining 48 h post-addition (from days 6 to 14) (Fig. 2A).
The results show that the cumulative administration of PTD4-
PI3KAc is able to increase the density of synapses at all ages studied,
although the effects aremore prominent during the first few days in
culture (Fig. 2A). The synaptogenic effect exhibits amaximumdur-
ing the first week in culture: 69.5  8.4% and 51.2  13.3% of
synaptic density increase after 6 and 8 d in vitro, respectively. This is
followedby a progressive reduction to a 32.8 11.3%, 24.0 9.0%,
and 25.7 0.8% increase at days 10, 12, and 14, respectively (n
440 neurons, four cultures) (Fig. 2G).
The density of synapses was also quantified 48 h after a single
application on day 10 (Fig. 2B). In these cultures, the density of
synapses increased to 42.8  8.5% (n  80, four cultures) (Fig.
2G). To test the effect in older cultures (3 weeks), a single treat-
ment was administered on day 19, and quantification was per-
formed at day 21. In this experiment, synaptic density increased
by 38.8  8.1% (Fig. 2C,G), a value similar to that obtained on
day 12 (n 80, three cultures).
To confirm the involvement of PI3K, an experiment in the
opposite direction was performed by inhibiting PI3K activity
with the selective inhibitor LY294002 (5 M). Its addition re-
duced synaptic density down by 40.9  6.3%, 48 h later (Fig.
2D–G), clearly implicating PI3K activity in synapse formation
and maintenance (n 40, two cultures).
The majority of the synaptic contacts present in hippocampal
neurons in culture are known to be glutamatergic (Rao et al.,
1998); under our culture conditions, the number of inhibitory
neurons was close to 6% (Benson et al., 1994). To study whether
the overactivation effects were synapse type specific (excitatory or
inhibitory), we quantified the changes in the number of inhibi-
tory and excitatory synapses using double immunostaining
against bassoon/PSD95 (Kornau et al., 1995) (Fig. 2E; supple-
mental Fig. S2, available at www.jneurosci.org as supplemental
material) and synapsing/gephyrin (a component of postsynaptic
GABAa and glycine synapses) (Kneussel and Betz, 2000) (Fig.
2F). The experimental data indicate that PI3K overactivation can
increase the density of both types of synapses 36.3 5.1% (n
60, two cultures) and 29.1 8.2% (n 60, two cultures), respec-
tively, for inhibitory and excitatory synapses (Fig. 2G).
The results of this experimental section, represented as the
percentage of increments normalized to the control cultures, are
summarized in Figure 2G. The progressive decrease in percentage
during the chronic treatment clearly indicates that some sort of
desensitization is taking place. The effectiveness of the PTD4-
PI3KAc treatment in the single-application experiments, com-
paring the effects on day 12 of the chronic and acute experiments,
also suggests that the cumulative presence of the peptide could
have a desensitizing effect.
Finally, from these experiments we conclude that the effect of
PI3K on synapse density is independent of the developmental
stage of the culture or the type of synapse.
The new synapses are functional
To address the functionality of these de novo synapses, we per-
formed electrophysiological recordings on cultured hippocam-
pal neurons, monitoring spontaneous miniature events. Under
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our recording conditions, at a holding membrane potential of
70 mV and in the presence of 2 mM MgCl2, the majority of
spontaneous miniature postsynaptic currents (mEPSCs) result
from postsynaptic AMPA receptor activation (Bekkers and Ste-
vens, 1989). Their frequency greatly depends on neuronal plating
density and culture age. Thus, tominimize variability, all cultures
were plated at the same cellular density, and electrophysiological
recordings were performed on 12-day-old cultures treated dur-
ing the previous 48 h with 5 g/ml PTD4-PI3KAc (Fig. 3A).
We compared the mean frequency (mEPSCs/min) under the
following three conditions: cultures treated with PTD4-PI3KAc
(5 g/ml); untreated cultures growing under the same condi-
tions; and cultures treated with transduction peptide PTD4 (5
g/ml) as a control for any possible changes attributable to the
transduction process. Despite the large variability among neu-
rons, the mean frequency average in the treated cells was signifi-
cantly higher than that of untreated and control cells (Fig. 3B).
The mEPSC frequency averages in untreated cells and those
treated with PTD4 were 22.4  3.5 and 21.4  3.8 per minute,
respectively, while in PTD4-PI3KAc-treated neurons it increased
to 29.1 4.2 perminute, representing a 29.9% increase (Fig. 3B).
Figure 2. PTD4-PI3KAc increases synaptogenesis in rat hippocampal neurons in culture. A,
Temporal evolution of synaptic density in a hippocampal neuronal culture. In untreated (con-
trol) cultures, synaptic density progressively increased. PTD4-PI3KAc (5 g/ml) was applied
every other day, starting on day 2. The density of synapses was analyzed on the indicated days.
Theestimatedmaximumcumulative concentrationof PTD4-PI3KAc is indicatedat the topof the
graph. The culture developed in the presence of the peptide showed significant differences on
all days (Student’s t test;n200neurons).B, Anexampleof theeffects of a singlePTD4-PI3KAc
application (5g/ml) on the density of synapses in a hippocampal neuronal culture of 10 d in
vitro (n 30 neurons). The density of synapses varied among cultures (see the comparison of
values at 12 d in vitro in A and B; see also Materials and Methods). Note, however, that the
treated cultures always showed density values higher than controls. C, Effects on the density of
synapses in a 3-week-old culture. PTD4-PI3KAc was added on day 19, and synaptic density
quantified onday21 (n30).D, Effects on thedensity of synapses after PI3K inhibition. Onday
19 in culturewere treatedwithLY294002 (5M), resulted ina significant loss in synapsedensity
48 h later (n 40). E, Effects over excitatory synapses. Synaptic density was evaluated on day
21. Excitatory synapses were identified by double staining with bassoon and PSD95 antibodies
(n 30). F, Effects over inhibitory synapses. Synaptic density was evaluated on day 12. Inhib-
itory synapses were identified by double immunostaining against gephyrin and synapsin (n
30). G, Summary plot of the synaptogenic effect. Left, Average data from six different cultures
chronically treatedwith PI3K activator, as inA. Synaptic increase showing abiphasic curve,with
amore pronounced effect during the first days in culture, followed by a decline (days 8 and 10),
and reachinganasymptotic valueonday10–14 in vitro. Right, Summaryof all acuteapplication
experiments, as shown in B–F. Similar percentages of increase were obtained in all culture
stages tested.
Figure 3. PI3K-induced synapses are functional. mEPSC frequency was recorded from hip-
pocampal neurons in culture under three experimental conditions: treatedwithPTD4-PI3KAc (5
g/ml); untreated; and treatedwithPTD4 (5g/ml). All treatments lasted48h, fromday10 to
12.A, Representative neuronal current traces showingmEPSCs. TTX 1Mwas regularly applied
to prevent evoked responses. B, Mean mEPSC frequency average plot. PTD4-PI3KAc treatment
resulted in an increase of 29% in mEPSC frequency. C, The cumulative frequency plot of all
recordedmEPSC sizes failed to show significant differences among treatments.D, MeanmEPSC
size plot. No differences were found among any of the treatments. A minimum of 10 neurons
from three different cultures were recorded for each condition.
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To test for possible changes inmEPSC quantal size, we compared
the mEPSC amplitude distribution under all three experimental
conditions. The cumulative graph did not indicate a significant
change in quantal size (Fig. 3C), suggesting that the treatment
does not modify the AMPA receptor sensitivity. The average
quantal sizes for untreated, PTD4-PI3KAc-treated, and PTD4-
treated cultures were 14.7 0.1 pA, 15.5 0.8 pA, and 15.1 1.2
pA, respectively (Fig. 3D). These data allow us to conclude that
PI3K activation induces the formation of new functional
synapses.
Synaptogenesis and dendritogenesis are differentially
modulated by PI3K
Previous studies using hippocampal neurons in culture indicate
that the constitutive activation of PI3K (overexpressing a mem-
brane tagged p110) modifies dendrite morphology during the
first 2 weeks in culture (Jaworski et al.,
2005). This feature raises the question of
whether modulation of the number of
synapses is coordinately regulated with
changes in dendritic complexity. To quanti-
tatively analyze the role of PI3K activation
over neuronal branching, we have used
the Sholl analysis (Sholl, 1953) on cells af-
ter 1, 2, and 3weeks in culture (Fig. 4A). A
microtubule-associated protein mono-
clonal antibody (MAP2B) was used to
stain the dendritic tree of neurons, either
untreated or treated with PTD4-PI3KAc
for 48 h, after 4–6 d in culture. PI3K acti-
vation failed tomodify dendritemorphol-
ogy at day 4 (Fig. 4B) (3.8 0.2 vs 3.4
0.2, respectively, crossings for control and
PI3K-activated neurons, n 56 for each
condition, four cultures), but it increased
the number of primary dendrites at day 6
from 4.7 0.2 to 5.7 0.5 crossings (Fig.
4C) (n 37 for each condition, four cul-
tures). This age coincides with the time at
which the stronger effects on synaptic
density were observed (Fig. 2G).
After 10 d in culture, neurons exhibit a
large and complex dendritic tree, which is
very difficult to trace as the arboriza-
tions fromdifferent neurons tend to over-
lap (Kaech and Banker, 2006). For this
reason, we transfected cells with aGFP en-
coding plasmid that allowed us to visual-
ize single-neuron arborizations. The PI3K
activation effects on dendritic branching
were studied on days 12 and 21, having
applied the peptide 48 h earlier. The Sholl
dendritic analysis indicated no differences
in arborization complexity between un-
treated and PTD4-PI3KAc-treated neu-
rons at 12 (10.7  0.5 vs 11.1  0.4
crossings, n 41 for each condition, three
cultures) or 21 (11.2  0.7 vs 10.9  0.6
crossings, n 34 for each condition, three
cultures) days in vitro (Fig. 4D,E). By con-
trast, the same treatment increased the
density of synapses by close to 40%at both
culture ages. Therefore, we can infer that
synaptogenesis and dendritogenesis are differentially regulated
by PI3K.
Synaptic increase is independent of cell density
Dendritic growth and synaptogenesis are independently regu-
lated by PI3K activation; however, it is still possible that if axonal
growth is underestimated by the Sholl analysis, it could contrib-
ute to the synaptogenic effect. In vitro, synaptic formation and
maturation depend to a large extent on neuronal plating density
and therefore of axonal complexity. Several factors such as the
presence of growth factors and, mainly, the distance the axon
must grow to find a target account for the actual synaptic density
(van den Pol et al., 1998). We reasoned that if PI3K-induced
synaptogenesis is dependent on new neuronal growth, either
dendritic or axonal, then the increase in synapses should be pro-
portional to the density of neurons. Thus, we measured the per-
Figure 4. PI3K promotes neurite branching only in young neurons.A, Representative digital thresholdmicrographs of neurons
stained with MAP2B (4 and 6 d in vitro) and transfected with CMV-GFP (12 and 21 d in vitro) in control (top) and PTD4-PI3KAc-
treated (48 h after the addition of 5g/ml) cultures (bottom). Scale bar, 10m. B–E, Sholl analysis graph of neuritic-dendritic
arborizations from untreated cultures (white circles) and treated (black circles). Analyses were performed at the indicated times.
The horizontal axis represents the distance from the cell soma, whereas the vertical axis shows the number of crossings. The
number of primary dendrites was statistically different from the controls only on day 6 in vitro (Student’s t test). div, Days in vitro.
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centage of synaptic increase after PTD4-PI3KAc treatment and
plotted it against the control synaptic density of each experiment
from the 48 h treatments only (Fig. 5). A linear regression with
either a positive or negative slope would indicate some degree of
correlation between both parameters.However, the linear regres-
sion of the data yields, a slope that is not statistically different
from zero ( y0.3 0.2 144.4; r2 0.13), indicating that
there is no association between these two variables. This result, in
combination with the Sholl analysis, further demonstrates that
PI3K activation has a direct synaptogenic effect that is indepen-
dent from neuritogenesis.
PI3K/Akt/mTOR regulates the expression of synaptic
proteins
We aimed to identify the main components of the canonical
PI3K-Akt signaling pathway. It is known that Akt is the major
signaling target of PI3K activation. To further characterize the
synaptogenic role played by Akt in our experiments, we used two
Akt inhibitors with different modes of action: Akt 1/2 inhibitor
and deguelin (Chun et al., 2003; Barnett et al., 2005). When hip-
pocampal cultures were treated with either Akt 1/2 inhibitor or
deguelin for 48 h, synapsin displayed a 50% reduction (Fig. 6A)
and phospho-Akt levels were also consistently reduced (Fig. 6A).
The combined addition of Akt 1/2 inhibitor and PTD4-PI3KAc
reduced synapsin levels by 41.2 16.3%, indicating a prevalence
of the inhibitor’s effect, which demonstrates that Akt is down-
stream from PI3K in the pathway (Fig. 6C). However, when
PSD95 levels were examined, Akt inhibition by deguelin or Akt
1/2 did not affect its levels, nor did PI3K inhibition by LY294002
(Fig. 6A,C). This result suggests a relatively slow turnover of
PSD95 with respect to presynaptic vesicular proteins (Ehlers,
2003; Velho and Mello, 2008).
One of the downstream Akt-regulated proteins, mTOR, is
involved in the control of cell size, synaptic plasticity, and axonal
regeneration, acting primarily through the phosphorylation of
p70S6K (Cammalleri et al., 2003; Hay and Sonenberg, 2004;
Jaworski and Sheng, 2006). This being the case, we proceeded to
examine the possible role of mTOR in PI3K-dependent synapto-
genesis by using its inhibitor (rapamycin). In neuronal cultures,
rapamycin (20 nM) reduces synapsin levels to 71.4  8.4% after
48 h of treatment (Fig. 6D,E). Interestingly, the combined action
of the PI3K activator and rapamycin increased synapsin levels by
25% (from the inhibited value to 97.1 13.9%). This percentage
was similar to that obtained when PTD4-PI3KAc was added by
itself (29%) (Fig. 1D). Since rapamycin did not block the effect of
PTD4-PI3KAc, the result is compatible with a PI3K-mediated
synaptogenic pathway independent of mTOR activation.
In parallel, the changes in synapse density after Akt/mTOR
inhibitionwere quantified in a 12-day-old culture treated for 48 h
with 20 nM rapamycin or 2.5 M Akt 1/2 inhibitor. On average,
synaptic density was reduced by 40% (37.8 and 40.8%, respec-
tively, after rapamycin and Akt 1/2 inhibitor; n  40, two cul-
tures) (Fig. 6F). Considered as a whole, the biochemical data
indicate that the increase in the density of synapses is accompa-
nied by an augmentation of synaptic protein expression, an effect
that is mediated by Akt independently of mTOR.
PI3K induces spinogenesis in adult neurons
Dendritic spines are the receptive sites for most excitatory
synapses in the mammalian nervous system. They are an ex-
cellent model for studies on synaptogenesis and short- and
long-term synaptic plasticity (Yuste and Bonhoeffer, 2004).
We studied the morphological plasticity of dendrites in vivo in
adult male rats (Sprague Dawley) by measuring spine density
after stereotaxic injections of PTD4-PI3KAc (1 l, 10 g/l)
in the dorsal hippocampus [bregma coordinates: 2.8 mm
anteroposterior, 1.5 mm lateral and 2.8 mm dorsoventral
(Paxinos andWatson, 1998)]. PTD4-rhodamine was used both as
a control of spine density and to monitor peptide diffusion in
control animals. After 72 h, experimental and control animals
were killed, and their brains were processed for Lucifer yellow
tracer microinjection and counterstained with an antibody
against Lucifer yellow to enhance the signal (Elston and Rosa,
1997; Benavides-Piccione et al., 2002; Ballesteros-Ya´n˜ez et al.,
2006) (Fig. 7A; supplemental Fig. S3, available at www.jneurosci.
org as supplemental material). As explained in Materials and
Methods, all measures were performed on basal dendritic seg-
ments starting 45 m away from the soma, since that is the dis-
tance at which spine density reaches a relatively constant value.
Spine density was quantified in hippocampal CA1 neurons of five
control (2646 spines from 44 dendrites, 5 animals) and five
treated rat brains (3050 spines, from 38 dendrites, 5 animals)
(Fig. 7C). The results indicate that PTD4-PI3KAc injections in-
creased spine density by 26% over the controls, raising the mean
average density from 0.95  0.03 under control conditions to
1.25 0.06 after the treatment.
Results in the same direction were obtained when the density
of spines was quantified in neurons in culture. In hippocampal
cultures, the dendritic spines begin to appear on days 16–18 in
vitro, and are abundant after 3 weeks of culture. To visualize and
quantify the density of spines, cultured hippocampal neurons
were transfected with a plasmid encoding GFP-actin (Fig. 7B).
GFP-actin localizes to spine heads in transfected neurons
(Fischer et al., 1998). In addition, we used synapsin as a presyn-
aptic marker. The data indicate that80–90% of the entire pop-
ulation of GFP-actin-positive spines also showed synapsin
immunostaining, which leads us to conclude that the majority of
the spines under our culture conditions were harboring mature
synapses (supplemental Fig. S4, available at www.jneurosci.org as
supplementalmaterial). By counting dendritic spines enriched in
GFP-actin (Fig. 7B), we quantified the density of spines on day 21
in culture, 48 h after adding the peptide (Fig. 7C). Remarkably,
PI3K activity also increased the density of spines in cultured neu-
rons, with an average increase from three cultures of 22% (Fig.
7C). To study the time required for PI3K to induce the formation
Figure 5. The synaptogenic effect does not depend on the density of synapses. Plot of
the percentage of synaptic increase (vertical axes) versus the initial synaptic density,
estimated from the control culture conditions. Only single-dose application experiments
(effect after 48 h) were plotted. Black circles represent total synapses (bassoon-synapsin),
closed squares correspond to excitatory synapses (bassoon/PSD95), and inverted triangles
indicate inhibitory synapses (gephyrin-synapsin). Linear regression of the experimental
points yields a line with a slope not significantly different from zero (n 23; y0.3
0.2 144.4; r 2 0.13).
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of new spines, we performed a time course experiment at 12, 24,
and 48 h. No significant differences were found 24 h after adding
the peptide; only after 48 h of treatment were the differences
between the control and treatment groups significantly different
(Fig. 7D). As expected, the PTD4 treatment did not elicit changes
in spine density (Fig. 7D). Considered together, the culture and in
vivo data indicate that PI3K activity is able to control the density
of spines in a fully mature system.
PI3K activation leads to changes in behavior
The correlation between spine density changes and learning and
memory processes is well documented (Segal, 2005). Our re-
ported increase in spine density in vivo prompted us to perform a
behavioral assay as functional proof of the activity of the de novo
synapses induced by PTD4-PI3KAc. To analyze any possible
changes in associative learning due to PI3K activation, we per-
formed a rodent contextual fear-conditioning test that evalu-
ates memory processes depending on the dorsal hippocampus
and the amygdala (Kim and Fanselow,
1992; Phillips and LeDoux, 1992; Lopez-
Fernandez et al., 2007). Animals were
matched according to their anxiety levels
(supplemental Figs. S5A, S6A, available at
www.jneurosci.org as supplemental ma-
terial) and distributed into two equivalent
groups, each receiving an intracerebral
ventricular injection of either the PTD4
transduction domain (control; n 10) or
the PTD4-PI3KAc peptide solution (10
g; n  10) 1 d before training. Interest-
ingly, while the PTD4-PI3KAc-injected
animals showed normal freezing re-
sponses to the shocks during conditioning
(t(18)  2,25; p  0.036) (Fig. 8A), they
displayed higher conditioned fear re-
sponses to the context (i.e., freezing) than
control animals when tested for memory
recall 24 h after conditioning (day 2, con-
text test) (Fig. 8A; see supplemental
movie SM1, available at www.jneurosci.
org as supplemental material). To discard
potential unspecific effects, freezing re-
sponses were also measured in a different
environment (i.e., contextual change);
however, no differences were observed
between control and treated animals, in-
dicating that the memory effects observed
in the PTD4-PI3KAc-treated animals are
context dependent (PTD4 15.2 2 and
PTD4-PI3KAc 17.4 3; n.s.) (see sup-
plemental movie SM2, available at www.
jneurosci.org as supplemental material).
Furthermore, to assess whether the ob-
served effects were specific to hippocam-
pal function or whether the peptide could
affect other learning or emotional pro-
cesses, we designed a new experiment to
test the effect of the peptide on acoustic
fear conditioning, an amygdala-depen-
dent (but not hippocampus-dependent)
task. To this end, two series of 11 animals,
matched as well for their anxiety levels
(supplemental Figs. S5B and S6B, avail-
able at www.jneurosci.org as supplemental material), were in-
jected with either PTD4-PI3KAc or PTD4 (10 g) 1 d before
training them for auditory fear conditioning. The results indi-
cate that PTD4-PI3KAc did not affect the memory required
for this task, with control and treated animals showing equiv-
alent freezing values both before and during tone exposure at
testing (n.s.) (Fig. 8B).
In parallel, to determine the efficiency of the peptide in mod-
ulating PI3K activity in vivo, we injected a new group of animals
with either PTD4-PI3KAc or PTD4 control peptide at the level of
the right lateral ventricle (n 3 for each condition). Forty-eight
hours after injection, the animals were killed and phospho-Akt
levels were measured in the right hippocampus of each animal.
The mean value of the three animals indicates a 27.4  7.8%
increase in phospho-Akt levels in PTD4-PI3KAc-injected ani-
mals (Fig. 8C,D). Similar results (a 35.1  15.1% increment)
were obtained when an ELISA phospho-Akt protocol was used
(data not shown). Together, these results strongly suggest that
Figure 6. Molecular signaling downstream of PI3K activation. A, Representative Western blot showing the Akt inhibition
effects. PSD95, synapsin, and phospho-Akt expression levelswere analyzed in response to Akt 1/2 inhibitor and deguelin. The PI3K
inhibitor LY294002was included as a negative control.B, RepresentativeWestern blot of PSD95, synapsin and phospho-Akt levels
in response to PTD4-PI3KAc alone or in combination with Akt 1/2 inhibitor. C, Summary graph of the effects of manipulating
PI3K-Akt signaling on synapsin and PSD95 regulation. Akt inhibition reduced synapsin basal levels by50% (Akt 1/2 inhibitor,
n 6; deguelin, n 4). The joint application of Akt 1/2 inhibitor and PTD4-PI3KAc reduced synapsin levels, blocking the synapsin
PI3K-dependent upregulation (n4). However,while PSD95 levels increased in hippocampal cultures treatedwith PTD4-PI3KAc,
no statistically significant differences were found among PSD95 levels when the PI3K-Akt pathway was inhibited (n 15).
Student’s t test.D, Representative immunoblot of synapsin levels after rapamycin-mediated inhibition ofmTOR. E, Average plot of
all experiments. Rapamycin reduced synapsin expression down to 71.4%. PTD4-PI3KAc combined with rapamycin counteracted
the effect of rapamycin alone, raising synapsin levels to 97.7% (n 7, three cultures). F, Synaptogenic effects of Akt/mTOR
inhibition in 19-day-old cultures treated for 48 h with the indicated concentrations. Synaptic density (synapsin/bassoon) was
reduced by 37.8 and 40.8%, respectively, after treatment with rapamycin and Akt inhibitor.
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PI3K activation facilitates associative learning in parallel to its
effect of increasing spine density.
Discussion
The data reported in this study demonstrate that PI3K signaling
mediates synaptogenesis and spinogenesis in mammalian neu-
rons. This increase in synapse density is independent of changes
in dendritic complexity and accompanied by an increase in syn-
aptic release activity in cultured neurons. Furthermore, when the
PI3K-activating peptide is injected in vivo, it enhances contextual
fear memory in rats.
Regulation of PI3K activity was achieved by transduction of a
peptide (PTD4-PI3KAc) mimicking a phosphorylated residue
that binds to the p85 regulatory subunit of PI3K. Transduction
peptides permit efficient delivery to all neurons and provide tem-
poral control over PI3K activation (Wadia et al., 2004).Using this
approach based on the interaction with the regulatory subunit
construct, we have been able to maintain PI3K activation within
physiological ranges and avoided several constraints associated
with the overexpression of the catalytic subunits of PI3K or con-
stitutively active Akt (Jaworski and Sheng, 2006).
The synaptogenic role of PI3K has been previously demon-
strated in Drosophila (Martín-Pen˜a et al., 2006). In this insect,
PI3Koverexpression leads to an approximately threefold increase
in the number of synapses in both young and agedneurons. In the
Figure7. PI3Kactivationpromotes spinogenesis in vivoand in vitro.A, Confocal images from
CA1 hippocampal neurons injected with Lucifer yellow. Top, Control animals. Bottom, PTD4-
PI3KAc-injected animals. Scale bar, 10m.B, Quantification of spine density changes in vitro in
GFP-actin-transfected cultured neurons. Top, A representative picture of a GFP-actin-
transfected neuron showing intense staining concentrated on the dendritic spines. On day 19,
hippocampal cultures were treated with either PTD4 (5g/ml) or PTD4-PI3KAc (5g/ml) for
48h. Pictures show representativedendrites fromhippocampal neurons in control (middle) and
PTD4-PI3KAc-treated (bottom) cultures. Scale bar, 10m. C, Summary of the effects on spine
density. Data represent the number of spines per micrometer of dendritic length. In vivo, mean
spinedensity increased from0.950.03 spines/min the controls to 1.250.06 spines/m
in treated animals (control: 2646 spines from44dendrites, five animals; treatment, 3050 spines
from 38 dendrites, five animals). In vitro, spine density in control cultures was 0.42 0.01
compared with 0.51 0.02 after 48 h of treatment. The number of dendrites analyzed was 78
(702 spines) under control conditions and 78 (839 spines) from three different treated cultures.
Statistically significant differences were found between control and treated groups. Student’s t
test, p 0.0059 and p 0.002, respectively, for in vivo and in vitro. D, In vitro spinogenesis
time course. GFP-actin-transfected neurons (19 d in vitro) were treated with 5 g/ml PTD4-
PI3KAc, the cells were processed, and the spines were quantified 12, 24, and 48 h later. Differ-
ences were only statistically different after 48 h (Student’s t test; n 700 spines from two
different cultures). As expected, PTD4 alone failed to induce changes in spine density.
Figure 8. Fear conditioning. Animals were intracerebrally ventricularly injected with either
10g of PTD4-PI3KAc (dark bars) orwith the PTD4 transduction domain (open bars) 1 d before
training. A, CFC: during training (i.e., conditioning), no differences in freezing values were
observed between control and treated rats (n 10 animals/group), either during the first 3
min of exploration or during the shock exposure phase (n.s.; Student’s t test, p 0.35), indi-
cating normal fear acquisition and no differences in sensitivity to the shocks. Context test: 24 h
later, PTD4-PI3KAc-treated rats showed higher freezing levels than controlwhen re-exposed to
the conditioning chambers with no shock delivery fear (Student’s t test, p 0.036). B, AFC:
during testing (i.e., 1 d after conditioning), no differences in freezing values were observed
between PTD4-PI3KAc-treated (n 11) and control (n 11) rats, either during the first 160 s
(no tone) or during the 5minof exposure to the conditioned tone (n.s; Student’s t test,p0.64
and p 0.124 before and after the tone respectively). C, RepresentativeWestern blot showing
thephospho-Akt levels 24h after intracerebral ventricular injections. Results fromhippocampal
samples of three controls (PTD4) and three treated rats (PTD4-PI3KAc) are shown. D, In vivo
Western blot quantification. On average, phospho-Akt levels were increased to 127.4 7.8%
over the control injected brains (n 3; Student	s t test, p 0.033).
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genetic approach used with flies, the PI3K catalytic domain
(Dp110) was spatial and temporally overexpressed only in specific
neurons by using the Gal4/UAS system (Brand and Perrimon,
1993). This genetic drivingmethod stronglymodifies the expression
levels of active protein, thus generating a higher synaptogenic effect
(Martín-Pen˜a et al., 2006).Despite thedifferences inmagnitude, our
results clearly demonstrate that the synaptogenic pathway involving
PI3K activation is conserved in mammals and has noticeable mor-
phological and functional effects.
Synaptogenesis and dendritogenesis are differentially
modulated by PI3K
Our results support a direct role of PI3K in regulating synapto-
genesis. The PI3K-Akt signaling pathway has been implicated in
morphogenesis and dendritic development (Rodgers and Theib-
ert, 2002; Cosker and Eickholt, 2007). Targeted-membrane p110
overexpression dramatically increases overall dendritic length
and complexity in young neurons, whereas no dendritic length
changes have been observed in hippocampal mature neurons
(15 d in culture) (Jaworski et al., 2005). Accordingly, inmature
cultures from 2 to 3 weeks in vitro, we found that PI3K activation
did not change dendritic complexity (Fig. 4). However, in cul-
tures of the same age, PI3K activation was able to increase synap-
tic density by 40%.
Axon polarization and elongation have been previously
shown to be modulated by PI3K, and its local activation at the
growth cone controls both processes through mPar3/mPar6 ac-
tivation (Shi et al., 2003; Sosa et al., 2006). This PI3K effect
prompted us to consider the possibility that an increase in axonal
sprouting could partially explain our results, due to the forma-
tion of more synapses in the new axonal branches. The dendritic
Sholl analysis could not completely rule out this possibility.How-
ever, several experimental observations allowed us to clarify this
issue. First, if more axonal collaterals were formed due to PI3K
overactivation, then synapse increase should be dependent on
axonal density and, in such cases, high neuronal density would
lead to higher synaptic increases. However, we observed no rela-
tionship between synaptic density and the percentage of increase
after PI3K overactivation (Fig. 5). Second, PI3K activation in a
fully developed in vivo system causes an increase in dendritic
spines (Fig. 7). In this mature system, axonal extension is less
likely to be responsible for the observed spine density increase. In
summary, all the observations indicate that the synaptogenic ef-
fects of PI3K must be distinct from those that control dendritic
growth in mammalian neurons.
Synaptogenic elements of the PI3K signaling cascade
The changes in synapse density are accompanied by an increase in
the levels of the ubiquitous presynaptic protein synapsin, as well
as those of the postsynaptic protein PSD95. The two structurally
different Akt inhibitors we used greatly reduced synapsin levels
(Fig. 6E). This inhibition abolished the synapsin increase elicited
by PI3K overactivation, indicating that the synaptogenic effect of
PI3K is mediated mainly by Akt activation (Fig. 6).
In contrast, PSD95 levels were unaffected by Akt inhibition.
We propose that differences in protein turnover between presyn-
aptic vesicular and postsynaptic components might explain this
difference (Ehlers, 2003; Velho andMello, 2008). A further com-
parative study on the average lifetime of these proteins should
determine whether this hypothesis is correct.
Another key element of the PI3K cascade is mTOR. The PI3K
pathway to mTOR is mediated by Akt, and results in the inhibi-
tion of tuberin and the activation of Rheb (a small GTPase ho-
molog of Ras), which in turn stimulates mTOR (Ma and Blenis,
2009). We found that mTOR inhibition by rapamycin reduced
synapsin expression and synaptic density (Fig. 6D–F), suggesting
that a basal mTOR activity contributes to synaptogenesis. More-
over, the combination of rapamycin and PTD4-PI3KAc failed to
inhibit the effects of PI3K activation. In fact, the percentage in-
crease in synapsin levels induced by PTD4-PI3KAc with respect
to the corresponding controls, rapamycin alone (25%) or the
vehicle alone (29%), was very similar. Considering these and
other experimental evidence from vertebrates and Drosophila
(Martín-Pen˜a et al., 2006), we suggest that the synaptogenic path-
way depends on PI3K-Akt through an mTOR-independent
mechanism, possibly involving other effectors not yet identified
downstream from the Akt signaling.
Spines
The role of the PI3K/Akt pathway in mature neurons, in which
specialized properties such as synapse number and polarity have
already been established, has been poorly studied. The results of
this study show that PI3K activation is able to induce supernu-
merary spines in culture and in vivo hippocampal neurons, sug-
gesting that the actual pathway sustaining PI3K synaptogenesis
also plays a role in regulating the density of spines. In addition,
previous experiments using a conditional PTEN knockdown in
the cerebral cortex and hippocampus ofmice show an increase in
phospho-Akt and mTOR/S6K, which resulted in increased spine
density (Kwon et al., 2006).
Several downstream elements of the PI3K signaling cascade
have been involved in the regulation of the Rho family of small
GTPases; furthermore, the activation of Ras by PI3K has been
shown to induce neuritic outgrowth in several neuronal cell lines
(Nusser et al., 2002). The small GTPases Rac1 and Cdc42 are key
regulators of actin-rich dendritic spine morphogenesis in neu-
rons. The expression of a constitutively active form of Rac1 in
Purkinje cells induces the growth of a large number of spines,
even though they are reduced in size (Luo et al., 1996).Moreover,
in hippocampal neurons, Rac1 activation promotes spine forma-
tion, while Rho activation prevents their formation (Tashiro et
al., 2000). Therefore, a PI3K-dependent mechanism for the co-
ordinated regulation of synaptogenesis and spinogenesis is plau-
sible through the control of Rac1 activation. Experiments using
specific Rac1 inhibitors will help to further investigate PI3K-
dependent spine induction.
New-born synapses are functional
Despite the great variability among cultures, hippocampal neu-
rons stimulated with PTD4-PI3KAc showed an increase in func-
tional synapses, as indicated by the basal mEPSC frequency
augmentation. This result is consistent with the role of PI3K in
maintaining PIP3 levels at postsynaptic densities and controlling
AMPA receptor turnover (Arendt et al., 2010). The increase in
mEPSC frequency (30%)was lower than expected, considering
the number of new synapses as defined bymorphological criteria.
Several reasons could account for this difference; most of these
new-born synapses may have a low probability of release or are
indeed silent synapses (Hanse et al., 2009). Additional electro-
physiological characterization of the calcium-evoked release will
help to elucidate this issue.
Importantly, PI3K activation was found to affect cognitive
behavior (Fig. 8). Contextual fear conditioning is mainly depen-
dent on two limbic structures: the amygdala and the dorsal hip-
pocampus, while auditory fear conditioning is amygdala (but not
hippocampus) dependent (Selden et al., 1991; KimandFanselow,
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1992; Phillips and LeDoux, 1992; Lopez-Fernandez et al., 2007).
Compared with control rats, animals injected intracerebrally
ventricularly with PTD4-PI3KAc showed improved contextual
(Fig. 8A), but not auditory (Fig. 8B) fear memory. These results
support the view that, under our experimental conditions, the
peptide is able to improve hippocampus-dependent memory.
These results fit in with the well documented role of PI3K in
synaptic plasticity. PI3K activity is required for the expression,
but not the induction, of long-term potentiation (LTP) in the
hippocampal CA1 region (Sanna et al., 2002). Studies performed
on the prefrontal cortex have demonstrated that LTP increases
the levels of Akt, mTOR, p70S6K, and 4E-BP1 phosphorylation;
conversely, the injection of PI3K ormTOR inhibitors suppressed
LTP induction (Sui et al., 2008). The enhancement in learning
ability presented here may result from a potentiation of synaptic
plasticity due to PI3K overactivation or, over a longer period of
time, itmay be a direct effect of the increase in hippocampal spine
density.
Together, this study shows that PI3K activation is a powerful
tool to regulate the density of synapses and spines in vitro and in
vivo, in young as well as in older mammalian neurons. More
relevant, the treatment that activates PI3K also elicits contextual
learning changes.On these grounds, the development of pharma-
cological tools based on the PI3K pathway may be of help in the
treatment of neurological disorders that are clinically character-
ized by synaptic and neuronal loss in specific brain areas.
References
Arendt KL, RoyoM, Ferna´ndez-MonrealM, Knafo S, PetrokCN,Martens JR,
Esteban JA (2010) PIP3 controls synaptic function by maintaining
AMPA receptor clustering at the postsynaptic membrane. Nat Neurosci
13:36–44.
Ballesteros-Ya´n˜ez I, Benavides-Piccione R, Elston GN, Yuste R, DeFelipe J
(2006) Density andmorphology of dendritic spines in mouse neocortex.
Neuroscience 138:403–409.
Banker G, Goslin K (1998) Culturing nerve cells. Cellular and molecular
neuroscience series (Stevens CF, ed.). Cambridge, MA: MIT Press.
Barnett SF, Defeo-Jones D, Fu S, Hancock PJ, Haskell KM, Jones RE, Kahana
JA, Kral AM, Leander K, Lee LL, Malinowski J, McAvoy EM, Nahas DD,
Robinson RG, Huber HE (2005) Identification and characterization of
pleckstrin-homology-domain-dependent and isoenzyme-specific Akt in-
hibitors. Biochem J 385:399–408.
Bekkers JM, Stevens CF (1989) NMDA and non-NMDA receptors are co-
localized at individual excitatory synapses in cultured rat hippocampus.
Nature 341:230–233.
Benavides-Piccione R, Ballesteros-Ya´n˜ez I, DeFelipe J, Yuste R (2002) Cor-
tical area and species differences in dendritic spine morphology. J Neuro-
cytol 31:337–346.
Benson DL, Watkins FH, Steward O, Banker G (1994) Characterization of
GABAergic neurons in hippocampal cell cultures. J Neurocytol
23:279–295.
Brand AH, Perrimon N (1993) Targeted gene expression as a means of al-
tering cell fates and generating dominant phenotypes. Development
118:401–415.
Brunet A, Datta SR, Greenberg ME (2001) Transcription-dependent and—
independent control of neuronal survival by the PI3K-Akt signaling path-
way. Curr Opin Neurobiol 11:297–305.
Cammalleri M, Lu¨tjens R, Berton F, King AR, Simpson C, Francesconi W,
Sanna PP (2003) Time-restricted role for dendritic activation of the
mTOR-p70S6K pathway in the induction of late-phase long-term poten-
tiation in the CA1. Proc Natl Acad Sci U S A 100:14368–14373.
ChunKH,Kosmeder JW2nd, Sun S, Pezzuto JM, LotanR,HongWK, LeeHY
(2003) Effects of deguelin on the phosphatidylinositol 3-kinase/Akt
pathway and apoptosis in premalignant human bronchial epithelial cells.
J Natl Cancer Inst 95:291–302.
Colicos MA, Collins BE, Sailor MJ, Goda Y (2001) (2001) Remodeling of
synaptic actin induced by photoconductive stimulation. Cell 107:605–
616.
Cosker KE, Eickholt BJ (2007) Phosphoinositide 3-kinase signalling events
controlling axonal morphogenesis. Biochem Soc Trans 35:207–210.
Derossi D, Williams EJ, Green PJ, Dunican DJ, Doherty P (1998) Stimula-
tion of mitogenesis by a cell-permeable PI 3-kinase binding peptide.
Biochem Biophys Res Commun 251:148–152.
Ehlers MD (2003) Activity level controls postsynaptic composition and sig-
naling via the ubiquitin-proteasome system. Nat Neurosci 6:231–242.
Elston GN, DeFelipe J (2002) Spine distribution in cortical pyramidal cells:
a common organizational principle across species. Prog Brain Res
136:109–133.
Elston GN, Rosa MG (1997) The occipitoparietal pathway of the macaque
monkey: comparison of pyramidal cell morphology in layer III of func-
tionally related cortical visual areas. Cereb Cortex 7:432–452.
Fischer M, Kaech S, Knutti D, Matus A (1998) Rapid actin-based plasticity
in dendritic spines. Neuron 20:847–854.
Fletcher TL, De Camilli P, Banker G (1994) Synaptogenesis in hippocampal
cultures: evidence indicating that axons and dendrites become competent
to form synapses at different stages of neuronal development. J Neurosci
14:6695–6706.
Franco B, Bogdanik L, Bobinnec Y, Debec A, Bockaert J, Parmentier ML,
Grau Y (2004) Shaggy, the homolog of glycogen synthase kinase 3, con-
trols neuromuscular junction growth in Drosophila. J Neurosci
24:6573–6577.
Friedman HV, Bresler T, Garner CC, Ziv NE (2000) Assembly of new indi-
vidual excitatory synapses: time course and temporal order of synaptic
molecule recruitment. Neuron 27:57–69.
Griffin RJ, Moloney A, Kelliher M, Johnston JA, Ravid R, Dockery P,
O’Connor R, O’Neill C (2005) Activation of Akt/PKB, increased phos-
phorylation of Akt substrates and loss and altered distribution of Akt and
PTEN are features of Alzheimer’s disease pathology. J Neurochem
93:105–117.
Hanse E, Taira T, Lauri S, Groc L (2009) Glutamate synapse in developing
brain: an integrative perspective beyond the silent state. Trends Neurosci
32:532–537.
Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes
Dev 18:1926–1945.
Ho A, Schwarze SR, Mermelstein SJ, Waksman G, Dowdy SF (2001) Syn-
thetic protein transduction domains: enhanced transduction potential in
vitro and in vivo. Cancer Res 61:474–477.
Humbert S, Bryson EA, Cordelie`res FP, Connors NC, Datta SR, Finkbeiner S,
Greenberg ME, Saudou F (2002) The IGF-1/Akt pathway is neuropro-
tective in Huntington’s disease and involves Huntingtin phosphorylation
by Akt. Dev Cell 2:831–837.
Jaworski J, Sheng M (2006) The growing role of mTOR in neuronal devel-
opment and plasticity. Mol Neurobiol 34:205–219.
Jaworski J, Spangler S, Seeburg DP, Hoogenraad CC, ShengM (2005) Con-
trol of dendritic arborization by the phosphoinositide-3	-kinase-Akt-
mammalian target of rapamycin pathway. J Neurosci 25:11300–11312.
Jiang H, Rao Y (2005) Axon formation: fate versus growth. Nat Neurosci
8:544–546.
Jiang H, Guo W, Liang X, Rao Y (2005) Both the establishment and the
maintenance of neuronal polarity require active mechanisms: critical
roles of GSK-3beta and its upstream regulators. Cell 120:123–135.
Kaech S, Banker G (2006) Culturing hippocampal neurons. Nat Protoc
1:2406–2415.
Kim JJ, Fanselow MS (1992) Modality-specific retrograde amnesia of fear.
Science 256:675–677.
Kneussel M, Betz H (2000) Receptors, gephyrin and gephyrin-associated
proteins: novel insights into the assembly of inhibitory postsynaptic
membrane specializations. J Physiol 525:1–9.
Kornau HC, Schenker LT, KennedyMB, Seeburg PH (1995) Domain inter-
action between NMDA receptor subunits and the postsynaptic density
protein PSD-95. Science 269:1737–1740.
Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, Zhang W, Li Y,
Baker SJ, Parada LF (2006) Pten regulates neuronal arborization and
social interaction in mice. Neuron 50:377–388.
Lin CH, Yeh SH, Lin CH, Lu KT, Leu TH, Chang WC, Gean PW (2001) A
role for the PI-3 kinase signaling pathway in fear conditioning and syn-
aptic plasticity in the amygdala. Neuron 31:841–851.
Lopez-FernandezMA,MontaronMF, Varea E, RougonG, Venero C, Abrous
DN Sandi C (2007) Upregulation of polysialylated neural cell adhesion
2732 • J. Neurosci., February 23, 2011 • 31(8):2721–2733 Cuesto et al. • Synaptogenic Role of PI3K
molecule in the dorsal hippocampus after contextual fear conditioning is
involved in long-term memory formation. J Neurosci 27:4552–4561.
LuoL,HenschTK,AckermanL, Barbel S, Jan LY, JanYN (1996) Differential
effects of the Rac GTPase on Purkinje cell axons and dendritic trunks and
spines. Nature 379:837–840.
Ma XM, Blenis J (2009) Molecular mechanism of mTOR mediate transla-
tional control. Nat Rev Mol Cell Biol 10:307–318.
Martín-Pen˜a A, Acebes A, Rodríguez JR, Sorribes A, de Polavieja GG,
Ferna´ndez-Fu´nez P, Ferru´s A (2006) Age-independent synaptogenesis
by phosphoinositide 3 kinase. J Neurosci 26:10199–10208.
MoralesM,ColicosMA,GodaY (2000) Actin-dependent regulation of neu-
rotransmitter release at central synapses. Neuron 27:539–550.
Nusser N, Gosmanova E, Zheng Y, Tigyi G (2002) Nerve growth factor sig-
nals through TrkA, phosphatidylinositol 3-kinase, and Rac1 to inactivate
RhoAduring the initiation of neuronal differentiation of PC12 cells. J Biol
Chem 277:35840–35846.
Opazo P, Watabe AM, Grant SG, O’Dell TJ (2003) Phosphatidylinositol
3-kinase regulates the induction of long-termpotentiation through extra-
cellular signal-related kinase-independent mechanisms. J Neurosci 23:
3679–3688.
Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, Ed 4.
San Diego, CA: Academic.
Phillips RG, LeDoux JE (1992) Differential contribution of amygdala and
hippocampus to cued and contextual fear conditioning. Behav Neurosci
106:274–285.
Rao A, Kim E, Sheng M, Craig AM (1998) Heterogeneity in the molecular
composition of excitatory postsynaptic sites during development of hip-
pocampal neurons in culture. J Neurosci 18:1217–1229.
Rodgers EE, Theibert AB (2002) Functions of PI 3-kinase in development of
nervous system. Int J Dev Neurosci 20:187–197.
RuggeroD, SonenbergN (2005) TheAkt of translational control. Oncogene
24:7426–7434.
Ruiz-Marcos A, Valverde F (1969) The temporal evolution of the distribution
of dendritic spines in the visual cortex of normal and dark raised mice.
Exp Brain Res 8:284–294.
Sanna PP, Cammalleri M, Berton F, Simpson C, Lutjens R, Bloom FE, Fran-
cesconi W (2002) Phosphatidylinositol 3-kinase is required for the ex-
pression but not for the induction or the maintenance of long-term
potentiation in the hippocampal CA1 region. J Neurosci 22:3359–3365.
Segal M (2005) Dendritic spines and long term plasticity. Nat Rev Neurosci
6:277–284.
Selden NR, Everitt BJ, Jarrard LE, Robbins TW (1991) Complementary
roles for the amygdala and hippocampus in aversive conditioning to ex-
plicit and contextual cues. Neuroscience 42:335–350.
Shapira M, Zhai RG, Dresbach T, Bresler T, Torres VI, Gundelfinger ED, Ziv
NE, Garner CC (2003) Unitary assembly of presynaptic active zones
from Piccolo-Bassoon transport vesicles. Neuron 38:237–252.
Shi SH, Jan LY, Jan YN (2003) Hippocampal neuronal polarity specified by
spatially localized mPar3/mPar6 and PI 3-kinase activity. Cell 112:63–75.
Sholl DA (1953) Dendritic organization in the neurons of the visual and
motor cortices of the cat. J Anat 87:387–406.
Sosa L, Dupraz S, Laurino L, Bollati F, Bisbal M, Ca´ceres A, Pfenninger KH,
Quiroga S (2006) IGF-1 receptor is essential for the establishment of
hippocampal neuronal polarity. Nat Neurosci 9:993–995.
Sudhof TC (2004) The synaptic vesicle cycle. Annu Rev Neurosci
27:509–547.
Sui L, Wang J, Li BM (2008) Role of the phosphoinositide 3-kinase-Akt-
mammalian target of the rapamycin signaling pathway in long-term po-
tentiation and trace fear conditioning memory in rat medial prefrontal
cortex. Learn Mem 15:762–776.
Tang SJ, Reis G, Kang H, Gingras AC, Sonenberg N, Schuman EM (2002) A
rapamycin-sensitive signaling pathway contributes to long-term synaptic
plasticity in the hippocampus. Proc Natl Acad Sci U S A 99:467–472.
Tashiro A, Minden A, Yuste R (2000) Regulation of dendritic spine mor-
phology by the rho family of small GTPases: antagonistic roles of Rac and
Rho. Cereb Cortex 10:927–938.
Tsokas P, Grace EA, Chan P,MaT, Sealfon SC, Iyengar R, Landau EM, Blitzer
RD (2005) Local protein synthesismediates a rapid increase in dendritic
elongation factor 1A after induction of late long-term potentiation.
J Neurosci 25:5833–5843.
van den Pol AN, Obrietan K, Belousov AB, Yang Y, Heller HC (1998) Early
synaptogenesis in vitro: role of axon target distance. J Comp Neurol
399:541–560.
Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC,
Woscholski R, Parker PJ, Waterfield MD (2001) Synthesis and function
of 3-phosphorylated inositol lipids. Annu Rev Biochem 70:535–602.
Velho TA, Mello CV (2008) Synapsins are late activity-induced genes regu-
lated by birdsong. J Neurosci 28:11871–11882.
Wadia JS, Stan RV,Dowdy SF (2004) Transducible TAT-HA fusogenic pep-
tide enhances escape of TAT-fusion proteins after lipid raftmacropinocy-
tosis. Nat Med 10:310–315.
Wymann MP, Pirola L (1998) Structure and function of phosphoinositide
3-kinases. Biochim Biophys Acta 1436:127–150.
Yoshimura T, ArimuraN,KawanoY, Kawabata S,Wang S, Kaibuchi K (2006)
Ras regulates neuronal polarity via the PI3-kinase/Akt/GSK-3beta/
CRMP-2 pathway. Biochem Biophys Res Commun 340:62–68.
Yu J, Zhang Y, McIlroy J, Rordorf-Nikolic T, Orr GA, Backer JM (1998)
Regulation of the p85/p110 phosphatidylinositol 3	-kinase: stabilization
and inhibition of the p110alpha catalytic subunit by the p85 regulatory
subunit. Mol Cell Biol 18:1379–1387.
Yuste R, Bonhoeffer T (2004) Genesis of dendritic spines: insights from ul-
trastructural and imaging studies. Nat Rev Neurosci 5:24–34.
Ziv NE, Garner CC (2001) Principles of glutamatergic synapse formation:
seeing the forest for the trees. Curr Opin Neurobiol 11:536–543.
Ziv NE, Garner CC (2004) Cellular and molecular mechanisms of presyn-
aptic assembly. Nat Rev Neurosci 5:385–399.
Cuesto et al. • Synaptogenic Role of PI3K J. Neurosci., February 23, 2011 • 31(8):2721–2733 • 2733
